Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent

ConclusionsOur investigation shows that gadolinium enhancement is strongly associated with age. Since gadolinium enhancement is a marker of inflammatory disease activity, our findings suggest that inflammatory disease activity declines with age, and that IMD treatment may be more beneficial in younger and less useful in older people with MS.
Source: Journal of Neurology - Category: Neurology Source Type: research